RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniele Generali, MD
SST di Cremona Multidisciplinare di Patologia Mammaria, Italy
Principal Investigator - Eva Ciruelos, MD
Madrid, Spain
Principal Investigator - Foluso Ademuyiwa, MD
Washington University School of Medicine, St Louis, USA
Principal Investigator - Joke Tio, MD
Munster, Germany
Principal Investigator - Maureen Trudeau, MD
Sunnybrook Health Sciences Center, Toronto, Canada
Principal Investigator - Thierry Petit, MD
Institut de Cancérologie, Strasbourg, France
Principal Investigator - Tomasz Jankowski, MD
NZOZ Neuromed, Lublin, Poland
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sunnybrook Health Sciences Center
Toronto, Canada
- Institut de Cancerologie de Strasbourg
Strasbourg, France
- Universitätsklinikum Münster
Münster, Germany
- Sst Di Cremona Multidisciplinare Di Patologia Mammaria, Italy
Cremona, Italy
- Nzoz Neuromed
Lublin, Poland
- Hospital U. 12 de Octubre
Madrid, Spain
- Siteman Cancer Center
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2018
- Primary completion
- 30 Oct 2026
- Completion
- 22 May 2031
- Last update posted
- 28 May 2026
- Registered enrollment
- 801
- Registry id
- NCT03524430
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.